Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,16119,180 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Targeting Nucleotide Metabolism to Overcome Therapy Resistance in Glioblastoma
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2026

ABSTRACT Glioblastoma (GBM) is the most common aggressive primary brain tumor and is uniformly fatal with a median survival of around 1.5-years. Like surgery and chemotherapy, radi...

$5.61M
USD
Completed NON-SBIR/STTR RPGS
Multi-atlas and whole body radiomics approaches for image-guided treatment of gynecologic cancers
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2024

ABSTRACT Gynecologic cancers are among the leading causes of cancer death in women worldwide. These patients typically are socioeconomically disadvantaged, with poor access to scre...

$2.65M
USD
Completed TRAINING, INDIVIDUAL
Cancer cell state interactions with immune populations of the tumor microenvironment
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2025

SUMMARY Tumors are complex systems composed of genetically and transcriptionally heterogeneous cells, and this variation has been implicated as a cause of drug resistance and morta...

$517.5K
USD
Completed TRAINING, INDIVIDUAL
Development of Small Molecule Inhibitor of PELP1 for Treating Advanced Breast Cancer
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT: Breast cancer (BC) is the most prevalent and second most lethal malignancy in females. Development of novel effective therapies for patients with therapy-...

$162K
USD
Completed TRAINING, INDIVIDUAL
Defining the Mechanistic Determinants of Response to Selective Electron Transport Chain Inhibition in Cancer
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2023

Abstract: Cells utilize two major modes of energy metabolism: glycolysis and oxidative phosphorylation (OXPHOS). Efforts to target metabolism in cancer have mainly focused on glyco...

$390K
USD
Completed TRAINING, INDIVIDUAL
Frequency and consequences of chromosome missegregation in breast cancer
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2023

PROJECT SUMMARY Research. Chromosomal instability (CIN) – observed as the first cancer hallmark over 100-years ago – is characterized by the persistent loss and gain of whole chrom...

$338.5K
USD
Completed TRAINING, INDIVIDUAL
Impact of the Breast Cancer Immune Microenvironment on Racial Disparities and Survivorship
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2022

PROJECT SUMMARY Breast cancer (BC) is the most commonly diagnosed malignancy and second leading cause of cancer-related deaths among women in the US. Among all BC cases, black wome...

$44K
USD
Completed TRAINING, INDIVIDUAL
Elucidating the role of somatic 3’UTR mutations in prostate cancer pathogenesis
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Research Center United States 2021 – 2022

PROJECT SUMMARY Prostate cancer is the second most common cause of cancer mortality in US men due to our poor understanding and treatment of metastatic, castration-resistant prosta...

$89.3K
USD
Completed TRAINING, INDIVIDUAL
Characterizing the role of SRCAP in Epidermal Homeostasis and Squamous Cell Carcinoma
NATIONAL CANCER INSTITUTE Northwestern University United States 2021 – 2025

Project Summary/Abstract Cutaneous squamous cell carcinoma (cSCC) is the second most common malignancy, disfiguring one million and killing 15,000 people per year in the United Sta...

$419.7K
USD
Completed TRAINING, INDIVIDUAL
The Role and Regulation of Monocarboxylate Transporters 1 and 4 in Epstein-Barr Virus-mediated B Lymphocyte Tumorigenesis
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2022

Epstein-Barr Virus (EBV) is a ubiquitous virus that establishes latency upon primary infection, but can hijack host metabolic pathways to promote tumorigenesis in immune-compromise...

$148.1K
USD
Completed TRAINING, INDIVIDUAL
Engineering Hybrid SynNotch CAR Receptors to Enhance Cell Therapies for Cancer
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2024

Chimeric Antigen T Cell (CAR-T) therapies, which redirect a patient’s own T cells towards their cancer, are very promising therapies for difficult to treat and refractory cancers....

$421.4K
USD
Completed TRAINING, INDIVIDUAL
Identifying the Role of Tumor Cell Intrinsic DNMT1 in Anti-Tumor Immunity in Pancreatic Ductal Adenocarcinoma
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

Project Summary Pancreatic ductal adenocarcinoma (PDAC) is currently the third leading cause of cancer-related death in the United States. The five-year survival rate of less than...

$517.5K
USD
Completed TRAINING, INDIVIDUAL
Investigating a Wnt-telomere feedback loop in the colorectal adenoma-carcinoma sequence
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2025

ABSTRACT: Colorectal adenocarcinoma (CRC) is a leading cause of cancer deaths globally. CRC tumorigenesis proceeds through a model of stepwise transformation of the colonic epithel...

$467.5K
USD
Completed NON-SBIR/STTR RPGS
Image-guided Interventional Combination Liver Cancer Immunotherapy
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2025

PROJECT SUMMARY For clinical application, a critical remaining hurdle for natural killer (NK) cell-based adoptive transfer immunotherapy (ATI) is the inadequate homing efficiency o...

$3.61M
USD
Completed TRAINING, INDIVIDUAL
The Mitochondrial Calcium Uniporter in Pancreatic Cancer Development, Metastasis, and Treatment
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2024

Summary: Pancreatic adenocarcinoma (PDAC) is a particularly lethal form of cancer which kills over 40,000 Americans every year. PDAC is most often diagnosed when disease is advance...

$675.8K
USD
Completed TRAINING, INDIVIDUAL
Elucidating the Role of C16orf72 in the Cellular Stress Response Network
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

PROJECT SUMMARY A hallmark of cancer is the ability of malignant cells to maintain viability in the face of stressors such as aneuploidy, nutrient scarcity, and xenobiotic compound...

$426.5K
USD
Completed NON-SBIR/STTR RPGS
Longitudinal Spatial-Nonspatial Decision Support for Competing Outcomes in Head and Neck Cancer Therapy
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2021 – 2026

Cancers that depend on the spatial location of the disease affect all ethnicities and age groups, accounting for significant mortality and therapy-related side effects. In one inst...

$1.16M
USD
Completed NON-SBIR/STTR RPGS
Image-based models of tumor-immune dynamics in glioblastoma
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2021 – 2026

ABSTRACT The use of immunotherapy to treat cancer continues to generate hope and excitement among those involved in cancer care and research. However, our inability to explain why...

$739.7K
USD
Completed NON-SBIR/STTR RPGS
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2021 – 2026

Project Summary Our early studies have characterized IL-9-producing CD4+ T helper (Th9) cells as an antitumor T cell subset. Recently, we also revealed Th9 cells as a novel T cell...

$4.03M
USD
Completed NON SBIR/STTR CONTRACTS
REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT
NATIONAL CANCER INSTITUTE Fisher Bioservices, Inc United States 2021 – 2023

The Drug Synthesis and Chemistry Branch (DSCB) of the Developmental Therapeutics Program (DTP) of the Division of Cancer Treatment and Diagnosis (DCTD) of the National Cancer Insti...

$25.58M
USD